Annual report pursuant to Section 13 and 15(d)

Acquisitions, Investments, and Licenses - Schedule of Consolidated Assets and Non-Recourse Liabilities (Details)

v2.4.0.8
Acquisitions, Investments, and Licenses - Schedule of Consolidated Assets and Non-Recourse Liabilities (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Current assets:        
Cash and cash equivalents $ 185,798 [1] $ 27,361 [1] $ 71,516 $ 18,016
Accounts receivable, net 19,767 [1] 21,162 [1]    
Inventory, net 18,079 [1] 22,261 [1]    
Prepaid expenses and other current assets 19,084 [1] 7,873 [1]    
Total current assets 242,728 [1] 78,657 [1]    
Property, plant and equipment, net 17,027 15,705    
Intangible assets, net 74,533 [1] 84,238 [1]    
Goodwill 226,373 [1] 80,450 [1] 39,815  
Other assets 6,861 [1] 2,777 [1]    
Total assets 1,391,516 [1] 289,830 [1]    
Current liabilities:        
Accounts payable 13,414 [1] 10,200 [1]    
Accrued expenses 65,874 [1] 24,656 [1]    
Total current liabilities 91,850 [1] 52,382 [1]    
Other long-term liabilities 214,775 [1] 34,168 [1]    
Total liabilities 518,537 [1] 86,550 [1]    
SciVac [Member] | Variable Interest Entity, Primary Beneficiary [Member]
       
Current assets:        
Cash and cash equivalents 2 174    
Accounts receivable, net 283 387    
Inventory, net 1,696 1,092    
Prepaid expenses and other current assets 218 199    
Total current assets 2,199 1,852    
Property, plant and equipment, net 1,374 1,539    
Intangible assets, net 1,111 1,154    
Goodwill 1,821 796    
Other assets 261 231    
Total assets 6,766 5,572    
Current liabilities:        
Accounts payable 1,136 1,108    
Accrued expenses 6,498 2,859    
Notes payable 1,537 0    
Total current liabilities 9,171 3,967    
Other long-term liabilities 1,240 1,529    
Total liabilities $ 10,411 $ 5,496    
[1] As of December 31, 2013 and 2012, total assets include $6.7 million and $5.6 million, respectively, and total liabilities include $10.4 million and $5.5 million, respectively related to SciVac Ltd (“SciVac”), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and the holders of SciVac’s consolidated liabilities have no recourse against us. Refer to Note 3.